BDK-IN-1
BDK-IN-1 (compound (-) -43) is a BDK inhibitor with the IC50 of 0.23 μM and the max inhibition of 90%. BDK-IN-1 decreases the level of phospho-E1 and can be used for study of cardiometabolic diseases[1].
Product Specifications
UNSPSC
12352005
Target
Endogenous Metabolite
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/bdk-in-1.html
Smiles
O=C([C@@H]1[C@@](C2)([H])C=C[C@@]2([H])[C@H]1C(NC3=NC(C4=CC=C(F)C=C4F)=CS3)=O)O
Molecular Formula
C18H14F2N2O3S
Molecular Weight
376.38
References & Citations
[1]Liang J, et al. Bicyclic Inhibitors of Branched-Chain α-Keto Acid Dehydrogenase Kinase (BDK) with In Vivo Activity. ACS Med Chem Lett. 2024;15 (11) :1899-1906.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TRC-D433985-250MG 250 mg
(1S)-(-)-(7,7-Dichloro-10-camphorsulfonyl)imine
Sign In for Pricing
View Details 
AP07079PU-N 50 µg
Melatonin Receptor 1B (MTNR1B) (N-Term, Extracel. Dom.) Rabbit Polyclonal Antibody
Sign In for Pricing
View Details 
HA723651B 100 µL
Mouse IL-21 Recombinant Rabbit monoclonal Antibody
Sign In for Pricing
View Details 